| Nano-and microparticulate drug carriers for targeting of the inflamed intestinal mucosa EM Collnot, H Ali, CM Lehr Journal of Controlled Release 161 (2), 235-246, 2012 | 292 | 2012 |
| Anti-neuroinflammatory potential of natural products in attenuation of Alzheimer's disease B Shal, W Ding, H Ali, YS Kim, S Khan Frontiers in pharmacology 9, 548, 2018 | 222 | 2018 |
| Budesonide loaded nanoparticles with pH-sensitive coating for improved mucosal targeting in mouse models of inflammatory bowel diseases H Ali, B Weigmann, MF Neurath, EM Collnot, M Windbergs, CM Lehr Journal of Controlled Release 183, 167-177, 2014 | 148 | 2014 |
| Advances in orally-delivered pH-sensitive nanocarrier systems; an optimistic approach for the treatment of inflammatory bowel disease M Zeeshan, H Ali, S Khan, SA Khan, B Weigmann International journal of pharmaceutics 558, 201-214, 2019 | 111 | 2019 |
| Poncirin attenuates CCL4-induced liver injury through inhibition of oxidative stress and inflammatory cytokines in mice H Ullah, A Khan, MW Baig, N Ullah, N Ahmed, MK Tipu, H Ali, S Khan BMC complementary medicine and therapies 20, 1-14, 2020 | 96 | 2020 |
| Medication adherence and its association with health literacy and performance in activities of daily livings among elderly hypertensive patients in Islamabad, Pakistan M Saqlain, A Riaz, MN Malik, S Khan, A Ahmed, S Kamran, H Ali Medicina 55 (5), 163, 2019 | 89 | 2019 |
| Antihyperalgesic properties of honokiol in inflammatory pain models by targeting of NF-κB and Nrf2 signaling S Khalid, MZ Ullah, AU Khan, R Afridi, H Rasheed, A Khan, H Ali, YS Kim, ... Frontiers in pharmacology 9, 140, 2018 | 88 | 2018 |
| Screening of budesonide nanoformulations for treatment of inflammatory bowel disease in an inflamed 3D cell-culture model F Leonard, H Ali, EM Collnot, BJ Crielaard, T Lammers, G Storm, CM Lehr ALTEX: Alternatives to Animal Experimentation 29 (3), 275-85, 2012 | 83 | 2012 |
| Budesonide loaded PLGA nanoparticles for targeting the inflamed intestinal mucosa—Pharmaceutical characterization and fluorescence imaging H Ali, B Weigmann, EM Collnot, SA Khan, M Windbergs, CM Lehr Pharmaceutical research 33, 1085-1092, 2016 | 82 | 2016 |
| Mucoprotective effects of Saikosaponin-A in 5-fluorouracil-induced intestinal mucositis in mice model J Ali, AU Khan, FA Shah, H Ali, SU Islam, YS Kim, S Khan Life Sciences 239, 116888, 2019 | 73 | 2019 |
| Attenuation of LPS-induced acute lung injury by continentalic acid in rodents through inhibition of inflammatory mediators correlates with increased Nrf2 protein expression H Ali, A Khan, J Ali, H Ullah, A Khan, H Ali, N Irshad, S Khan BMC Pharmacology and Toxicology 21, 1-14, 2020 | 62 | 2020 |
| Attenuation of inflammatory pain by puerarin in animal model of inflammation through inhibition of pro-inflammatory mediators MZ Ullah, AU Khan, R Afridi, H Rasheed, S Khalid, M Naveed, H Ali, ... International immunopharmacology 61, 306-316, 2018 | 61 | 2018 |
| Topical delivery of curcumin-loaded transfersomes gel ameliorated rheumatoid arthritis by inhibiting NF-κβ pathway E Sana, M Zeeshan, QU Ain, AU Khan, I Hussain, S Khan, E Lepeltier, ... Nanomedicine 16 (10), 819-837, 2021 | 57 | 2021 |
| Drug delivery to macrophages: A review of nano-therapeutics targeted approach for inflammatory disorders and cancer M Mukhtar, H Ali, N Ahmed, R Munir, S Talib, AS Khan, R Ambrus Expert opinion on drug delivery 17 (9), 1239-1257, 2020 | 54 | 2020 |
| Antinociceptive properties of 25‐methoxy hispidol A, a triterpinoid isolated from Poncirus trifoliata (Rutaceae) through inhibition of NF‐κB signalling in mice A Khan, MZ Ullah, R Afridi, H Rasheed, S Khalid, H Ullah, H Ali, ... Phytotherapy research 33 (2), 327-341, 2019 | 53 | 2019 |
| Glycyrrhizic acid-loaded pH-sensitive poly-(lactic-co-glycolic acid) nanoparticles for the amelioration of inflammatory bowel disease M Zeeshan, H Ali, S Khan, M Mukhtar, MI Khan, M Arshad Nanomedicine 14 (15), 1945-1969, 2019 | 50 | 2019 |
| Matrine alleviates neurobehavioral alterations via modulation of JNK-mediated caspase-3 and BDNF/VEGF signaling in a mouse model of burn injury A Khan, B Shal, M Naveed, B Nasir, N Irshad, H Ali, S Khan Psychopharmacology 237, 2327-2343, 2020 | 48 | 2020 |
| Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators S Khalid, A Khan, B Shal, H Ali, YS Kim, S Khan Biomedicine & Pharmacotherapy 114, 108777, 2019 | 45 | 2019 |
| Anomalin attenuates LPS-induced acute lungs injury through inhibition of AP-1 signaling A Khan, S Khan, H Ali, KU Shah, H Ali, O Shehzad, A Onder, YS Kim International immunopharmacology 73, 451-460, 2019 | 42 | 2019 |
| A new cationic palladium (II) dithiocarbamate exhibits anti-inflammatory, analgesic, and antipyretic activities through inhibition of inflammatory mediators in in vivo models M Naveed, SZ Khan, S Zeeshan, A Khan, B Shal, A Atiq, H Ali, R Ullah, ... Naunyn-Schmiedeberg's archives of pharmacology 392, 961-977, 2019 | 41 | 2019 |
